A relapsing immune thrombocytopenia case in a patient following COVID-19 vaccination
Yükleniyor...
Tarih
2022
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Thieme Medical Publishers Inc
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
There are several vaccines developed against COVID-19 infection. Inactivated viral vaccines are usually well tolerated. We aimed to present a relapsing immune thrombocytopenia case following inactive COVID-19 vaccine. Here we report a case of relapsing immune thrombocytopenia following inactivated viral vaccine against COVID-19 in a 60-year-old woman with a history of immune thrombocytopenia. The patient responded well to dexamethasone treatment and was discharged from the hospital with full recovery. We suggest that physicians seek the history of a recent inactivate COVID-19 vaccine shot in patients with immune thrombocytopenia.
Açıklama
Anahtar Kelimeler
COVID-19, Immune Thrombocytopenia, Inactivated Viral Vaccine
Kaynak
Journal of Health and Allied Sciences NU
WoS Q Değeri
N/A
Scopus Q Değeri
Cilt
12
Sayı
1
Künye
Tel, B. M. A., Kahveci, G., Duman, T. T., Kurtkulagi, Ö., Bilgin, S., Senturk, H., ... & Aktas, G. (2022). A relapsing immune thrombocytopenia case in a patient following COVID-19 vaccination. Journal of Health and Allied Sciences NU, 12(01), 96-97.
